BioCentury
ARTICLE | Financial News

Versant launches Black Diamond to mine allosteric mutant oncogenes

December 11, 2018 1:05 PM UTC

Black Diamond Therapeutics Inc. (New York City, N.Y.) emerged from stealth on Tuesday with $20 million in a tranched series A round from Versant Ventures and a platform to find and drug allosteric mutant oncogenes (see "Black Diamond: Mapping Allostery").

It is the first company to launch from Versant's Ridgeline incubator in Basel. ...